Location History:
- Oak Park, IL (US) (1993 - 2003)
- Occidental, CA (US) (2010)
Company Filing History:
Years Active: 1993-2010
Title: **The Innovative Path of Noel P. Bouck**
Introduction
Noel P. Bouck, an accomplished inventor based in Oak Park, Illinois, has made significant contributions to the field of medical research and innovation. With a portfolio of six patents, his work primarily focuses on methods and compositions that target angiogenesis, a crucial process in tumor development and other pathological conditions.
Latest Patents
Among Noel P. Bouck's latest innovations are two notable patents that center on the inhibition of angiogenesis. The first patent outlines a method of inhibiting angiogenesis within tissue by introducing exogenous Pigment Epithelium-Derived Factor (PEDF) to the cells. This innovation demonstrates how exogenous PEDF interferes with the vascular endothelial cells, limiting their ability to expand and subsequently reduce angiogenesis. Furthermore, this invention includes a method for assessing tumor severity by detecting PEDF levels within the tumor, alongside pharmaceutical compositions that comprise sources of PEDF. The second patent mirrors the concepts outlined in the first, utilizing exogenous SLED (Short-Form-Like Endothelial-Derived Factor) to inhibit tissue angiogenesis and determine tumor severity through assays for SLED presence.
Career Highlights
Throughout his career, Noel has been associated with prestigious institutions such as Northwestern University and Abbott Laboratories Corporation. His work at these organizations has laid the groundwork for groundbreaking innovations at the intersection of biotechnology and medicine.
Collaborations
In his journey as an inventor, Noel P. Bouck has collaborated with notable professionals in the industry, including David W. Dawson and Paul R. Gillis. These partnerships have not only enhanced his work's impact but have also contributed to the advancement of knowledge in the field of angiogenesis.
Conclusion
Noel P. Bouck's innovative spirit and commitment to research shine through his contributions to medical science. His patents are vital in understanding and treating conditions related to angiogenesis, making significant strides towards improved patient outcomes. As he continues his work, the implications of his innovations will undoubtedly lead to further advancements and a better understanding of tumor biology.